Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Bases de dados
Ano de publicação
Tipo de documento
Revista
Intervalo de ano de publicação
1.
Sleep ; 40(12)2017 12 01.
Artigo em Inglês | MEDLINE | ID: mdl-29029309

RESUMO

Objectives: To investigate the effects of caffeine on psychomotor vigilance and sleepiness during sleep restriction and following subsequent recovery sleep. Methods: Participants were N = 48 healthy good sleepers. All participants underwent five nights of sleep satiation (time-in-bed [TIB]: 10 hours), followed by five nights of sleep restriction (TIB: 5 hours), and three nights of recovery sleep (TIB: 8 hours) in a sleep laboratory. Caffeine (200 mg) or placebo was administered in the form of chewing gum at 08:00 am and 12:00 pm each day during the sleep restriction phase. Participants completed hourly 10-minute psychomotor vigilance tests and a modified Maintenance of Wakefulness Test approximately every 4 hours during the sleep restriction and recovery phases. Results: Caffeine maintained objective alertness compared to placebo across the first 3 days of sleep restriction, but this effect was no longer evident by the fourth day. A similar pattern of results was found for Maintenance of Wakefulness Test sleep latencies, such that those in the caffeine group (compared to placebo) did not show maintenance of wakefulness relative to baseline after the second night of restriction. Compared to placebo, participants in the caffeine condition displayed slower return to baseline in alertness and wakefulness across the recovery sleep period. Finally, the caffeine group showed greater N3 sleep duration during recovery. Conclusions: Caffeine appears to have limited efficacy for maintaining alertness and wakefulness across 5 days of sleep restriction. Perhaps more importantly, there may be recovery costs associated with caffeine use following conditions of prolonged sleep loss.


Assuntos
Nível de Alerta/efeitos dos fármacos , Cafeína/administração & dosagem , Desempenho Psicomotor/efeitos dos fármacos , Recuperação de Função Fisiológica/efeitos dos fármacos , Privação do Sono/tratamento farmacológico , Vigília/efeitos dos fármacos , Adulto , Nível de Alerta/fisiologia , Atenção/efeitos dos fármacos , Atenção/fisiologia , Feminino , Humanos , Masculino , Polissonografia/efeitos dos fármacos , Polissonografia/tendências , Desempenho Psicomotor/fisiologia , Recuperação de Função Fisiológica/fisiologia , Sono/efeitos dos fármacos , Sono/fisiologia , Privação do Sono/fisiopatologia , Privação do Sono/psicologia , Fases do Sono/efeitos dos fármacos , Fases do Sono/fisiologia , Resultado do Tratamento , Vigília/fisiologia , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA